StocksISRG

ISRG

Intuitive Surgical, Inc.Healthcare / Medical Instruments & SuppliesINTACT

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Share Price
$369.15
52W: $328.57 - $603.88
DCF Fair Value
$236.89
-55.8% Premium
P/E (TTM)
42.3x
ROIC
25.2%
Operating Margin
33.6%
FCF Yield
2%
Debt / Equity
0.15x
Piotroski Score
7/9
Altman Z-Score
2.96
Market Cap
$132.3B

Price vs. Intrinsic Value Corridor

Overvalued vs DCF ($236.89)

Historical market price overlaid against conservative DCF Fair Value & Benjamin Graham Margin of Safety bands.

Period Return (1Y)
()
Period Range
$ - $
DCF Fair Value
$236.89
MOS Buy Target (-25%)
$177.67
Valuation Overlays:

2-Stage Discounted Cash Flow (DCF) Workbench

Conservative intrinsic value model based on owner cash generation over a 10-year investment horizon. Opens with LocalAlpha's baseline assumptions (matching the fair value shown above) — adjust any input to stress-test.

Current Market Price
$369.15
DCF Fair Value
$237.03
-55.7% Premium
$2,615M
$100M$2,615M (Reported)$50,000M
16.8%
-5%10% (Target)35%
4.5%
0%5%20%
9.0%
6%9% (Standard)15% (High Risk)
2.5%
1% (GDP Floor)2.5% (Inflation)4.0%
-$5,200M (Net Cash)
-$100B CashBalance Sheet+$150B Debt
10-Yr PV of Cash Flows
$32.5B
PV of Terminal Value
$47.2B
Implied Enterprise Value
$79.7B
Implied Equity Value
$84.9B
YearYr 1Yr 2Yr 3Yr 4Yr 5Yr 6Yr 7Yr 8Yr 9Yr 10
Projected FCF ($M)$3,054$3,567$4,167$4,867$5,684$5,940$6,208$6,487$6,779$7,084
Present Value (PV)$2,802$3,003$3,218$3,448$3,694$3,542$3,396$3,256$3,121$2,992

Benjamin Graham & Buffett Value Models

Classical deep value metrics based on asset backing, normalized earnings power, and owner cash yield.

Graham Number-267.8% Premium
$100.36

Calculated as √(22.5 × EPS × BVPS). The maximum theoretical price a defensive investor should pay based purely on asset book value and current earnings.

EPS: $8.72BVPS: $51.34
Revised Graham Formula-37% Premium
$269.38

Formula: V = (EPS × (8.5 + 2g) × 4.4) / Y where g is the conservative 7-10 yr growth rate and Y is AAA Bond Yield.

Buffett Owner Earnings1.9% Yield
$6.94 / share

True distributable cash flow: Net Income + D&A - Maintenance CapEx. Reflects the cash Buffett would extract without hurting unit volume.

Total: $2.5BYield: 1.9%

Reverse DCF: Market Growth Expectation

HIGH BARRIER
17.9% CAGR (Next 10 Yrs)

At the current price of $369.15, the market is assuming the business will compound Free Cash Flow at 17.9% per year for the next decade with a 9% hurdle rate.

Value Investor Verdict
ℹ Fair expectations: Requires steady execution.
Autonomous Thesis Underwriting

Surveil ISRG with Mathematical Margin of Safety Rules

Set non-negotiable floor rules for Intuitive Surgical, Inc.. If a newly filed quarterly 10-Q breaks your ROIC floor, operating margin boundary, or balance sheet leverage rules, receive an autonomous breach audit within 15 minutes.

Buffett Quality

ROIC > 15% • Margin > 15% • D/E < 0.5x

Margin Floor Guard

Current Margin 33.6% • Floor > 10%

Solvency Guard

Altman-Z > 2.6 • Current Ratio > 1.5x

Frequently Asked Questions: Intuitive Surgical, Inc. (ISRG) Intrinsic Valuation

Audited fundamentals, DCF intrinsic value sensitivity, and thesis break detection parameters for Intuitive Surgical, Inc..

Based on institutional multi-stage Discounted Cash Flow (DCF) modeling on audited SEC cash flows, Intuitive Surgical, Inc. has an estimated DCF intrinsic fair value of $236.89 per share compared to its current market price of $369.15. This represents an estimated 55.8% premium over fair value. Additionally, its classic Benjamin Graham Number stands at $100.36.

Related Healthcare Value Stocks & Sector Peers

Compare Intuitive Surgical, Inc. with audited intrinsic valuation models across the Healthcare sector.

View All S&P 500 Stocks